APO Research
Talk to an analyst

APO RESEARCH · REPORT

NSAIDs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global NSAIDs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025197 pages

Choose your research edition.

Industry ResearchNSAIDs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal NSAIDs Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal NSAIDs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NSAIDs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal NSAIDs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global NSAIDs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of NSAIDs include Cigna, Geri-Care Pharmaceuticals, GlaxoSmithKline, Kopran, Novacap, Perrigo Company, Reddy Pharmaceuticals, Sun Pharmaceutical Industries and Verywell, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global NSAIDs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NSAIDs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NSAIDs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NSAIDs market size, projected growth trends, production technologies, key applications, and end-use industries.

NSAIDs Segment by Company

Cigna

Geri-Care Pharmaceuticals

GlaxoSmithKline

Kopran

Novacap

Perrigo Company

Reddy Pharmaceuticals

Sun Pharmaceutical Industries

Verywell

Bayer

Pfizer

Merck Sharp & Dohme

Johnson & Johnson

Abbott

NSAIDs Segment by Type

Naproxen

Nabumetone

Ibuprofen

Aspirin

Others

NSAIDs Segment by Application

Back Pain Treatment

Osteoarthritis Treatment

Other Disease Treatment

NSAIDs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NSAIDs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NSAIDs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NSAIDs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the NSAIDs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of NSAIDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of NSAIDs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of NSAIDs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. NSAIDs Industry Trends Table 2. NSAIDs Industry Drivers Table 3. NSAIDs Industry Opportunities and Challenges Table 4. NSAIDs Industry Restraints Table 5. Global NSAIDs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global NSAIDs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global NSAIDs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global NSAIDs Sales Market Share by Manufacturers Table 9. Global NSAIDs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global NSAIDs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global NSAIDs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global NSAIDs Manufacturers, Product Type & Application Table 13. Global NSAIDs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global NSAIDs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Naproxen Table 17. Major Manufacturers of Nabumetone Table 18. Major Manufacturers of Ibuprofen Table 19. Major Manufacturers of Aspirin Table 20. Major Manufacturers of Others Table 21. Global NSAIDs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global NSAIDs Sales by Type (2021-2026) & (K Units) Table 23. Global NSAIDs Sales by Type (2027-2032) & (K Units) Table 24. Global NSAIDs Sales Market Share by Type (2021-2026) Table 25. Global NSAIDs Sales Market Share by Type (2027-2032) Table 26. Global NSAIDs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global NSAIDs Revenue by Type (2021-2026) & (K Units) Table 28. Global NSAIDs Revenue by Type (2027-2032) & (K Units) Table 29. Global NSAIDs Revenue Market Share by Type (2021-2026) Table 30. Global NSAIDs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Back Pain Treatment Table 32. Major Manufacturers of Osteoarthritis Treatment Table 33. Major Manufacturers of Other Disease Treatment Table 34. Global NSAIDs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global NSAIDs Sales by Application (2021-2026) & (K Units) Table 36. Global NSAIDs Sales by Application (2027-2032) & (K Units) Table 37. Global NSAIDs Sales Market Share by Application (2021-2026) Table 38. Global NSAIDs Sales Market Share by Application (2027-2032) Table 39. Global NSAIDs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global NSAIDs Revenue by Application (2021-2026) & (K Units) Table 41. Global NSAIDs Revenue by Application (2027-2032) & (K Units) Table 42. Global NSAIDs Revenue Market Share by Application (2021-2026) Table 43. Global NSAIDs Revenue Market Share by Application (2027-2032) Table 44. Global NSAIDs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global NSAIDs Sales by Region (2021-2026) & (K Units) Table 46. Global NSAIDs Sales Market Share by Region (2021-2026) Table 47. Global NSAIDs Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global NSAIDs Sales Forecasted Market Share by Region (2027-2032) Table 49. North America NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America NSAIDs Sales by Country (2021-2026) & (K Units) Table 51. North America NSAIDs Sales by Country (2027-2032) & (K Units) Table 52. Europe NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe NSAIDs Sales by Country (2021-2026) & (K Units) Table 54. Europe NSAIDs Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific NSAIDs Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific NSAIDs Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa NSAIDs Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa NSAIDs Sales by Country (2027-2032) & (K Units) Table 61. Global NSAIDs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global NSAIDs Revenue by Region (2021-2026) & (US$ Million) Table 63. Global NSAIDs Revenue by Region (2027-2032) & (US$ Million) Table 64. Global NSAIDs Revenue Market Share by Region (2021-2026) Table 65. Global NSAIDs Revenue Market Share by Region (2027-2032) Table 66. Cigna Company Information Table 67. Cigna Business Overview Table 68. Cigna NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Cigna NSAIDs Product Portfolio Table 70. Cigna Recent Development Table 71. Geri-Care Pharmaceuticals Company Information Table 72. Geri-Care Pharmaceuticals Business Overview Table 73. Geri-Care Pharmaceuticals NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Geri-Care Pharmaceuticals NSAIDs Product Portfolio Table 75. Geri-Care Pharmaceuticals Recent Development Table 76. GlaxoSmithKline Company Information Table 77. GlaxoSmithKline Business Overview Table 78. GlaxoSmithKline NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. GlaxoSmithKline NSAIDs Product Portfolio Table 80. GlaxoSmithKline Recent Development Table 81. Kopran Company Information Table 82. Kopran Business Overview Table 83. Kopran NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Kopran NSAIDs Product Portfolio Table 85. Kopran Recent Development Table 86. Novacap Company Information Table 87. Novacap Business Overview Table 88. Novacap NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Novacap NSAIDs Product Portfolio Table 90. Novacap Recent Development Table 91. Perrigo Company Company Information Table 92. Perrigo Company Business Overview Table 93. Perrigo Company NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Perrigo Company NSAIDs Product Portfolio Table 95. Perrigo Company Recent Development Table 96. Reddy Pharmaceuticals Company Information Table 97. Reddy Pharmaceuticals Business Overview Table 98. Reddy Pharmaceuticals NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Reddy Pharmaceuticals NSAIDs Product Portfolio Table 100. Reddy Pharmaceuticals Recent Development Table 101. Sun Pharmaceutical Industries Company Information Table 102. Sun Pharmaceutical Industries Business Overview Table 103. Sun Pharmaceutical Industries NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Sun Pharmaceutical Industries NSAIDs Product Portfolio Table 105. Sun Pharmaceutical Industries Recent Development Table 106. Verywell Company Information Table 107. Verywell Business Overview Table 108. Verywell NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Verywell NSAIDs Product Portfolio Table 110. Verywell Recent Development Table 111. Bayer Company Information Table 112. Bayer Business Overview Table 113. Bayer NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Bayer NSAIDs Product Portfolio Table 115. Bayer Recent Development Table 116. Pfizer Company Information Table 117. Pfizer Business Overview Table 118. Pfizer NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Pfizer NSAIDs Product Portfolio Table 120. Pfizer Recent Development Table 121. Merck Sharp & Dohme Company Information Table 122. Merck Sharp & Dohme Business Overview Table 123. Merck Sharp & Dohme NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Merck Sharp & Dohme NSAIDs Product Portfolio Table 125. Merck Sharp & Dohme Recent Development Table 126. Johnson & Johnson Company Information Table 127. Johnson & Johnson Business Overview Table 128. Johnson & Johnson NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Johnson & Johnson NSAIDs Product Portfolio Table 130. Johnson & Johnson Recent Development Table 131. Abbott Company Information Table 132. Abbott Business Overview Table 133. Abbott NSAIDs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Abbott NSAIDs Product Portfolio Table 135. Abbott Recent Development Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. NSAIDs Distributors List Table 139. NSAIDs Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. NSAIDs Product Image Figure 2. Global NSAIDs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NSAIDs Market Size (2021-2032) & (US$ Million) Figure 4. Global NSAIDs Sales (2021-2032) & (K Units) Figure 5. Global NSAIDs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 NSAIDs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Naproxen Image Figure 9. Nabumetone Image Figure 10. Ibuprofen Image Figure 11. Aspirin Image Figure 12. Others Image Figure 13. Global NSAIDs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global NSAIDs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global NSAIDs Sales Market Share by Type (2021-2032) Figure 16. Global NSAIDs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global NSAIDs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global NSAIDs Revenue Market Share by Type (2021-2032) Figure 19. Back Pain Treatment Image Figure 20. Osteoarthritis Treatment Image Figure 21. Other Disease Treatment Image Figure 22. Global NSAIDs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global NSAIDs Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global NSAIDs Sales Market Share by Application (2021-2032) Figure 25. Global NSAIDs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global NSAIDs Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global NSAIDs Revenue Market Share by Application (2021-2032) Figure 28. North America NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America NSAIDs Sales Market Share by Country (2021-2032) Figure 30. U.S. NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe NSAIDs Sales Market Share by Country (2021-2032) Figure 35. Germany NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific NSAIDs Sales Market Share by Country (2021-2032) Figure 42. China NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa NSAIDs Sales Market Share by Country (2021-2032) Figure 50. Brazil NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile NSAIDs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global NSAIDs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global NSAIDs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America NSAIDs Revenue (2021-2032) & (US$ Million) Figure 61. North America NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe NSAIDs Revenue (2021-2032) & (US$ Million) Figure 63. Europe NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific NSAIDs Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa NSAIDs Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. NSAIDs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. NSAIDs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Naproxen
  • Nabumetone
  • Ibuprofen
  • Aspirin
  • Others
Applications
  • Back Pain Treatment
  • Osteoarthritis Treatment
  • Other Disease Treatment
Companies covered
  • Cigna
  • Geri-Care Pharmaceuticals
  • GlaxoSmithKline
  • Kopran
  • Novacap
  • Perrigo Company
  • Reddy Pharmaceuticals
  • Sun Pharmaceutical Industries
  • Verywell
  • Bayer
  • Pfizer
  • Merck Sharp & Dohme
  • Johnson & Johnson
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global NSAIDs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global NSAIDs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global NSAIDs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global NSAIDs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global NSAIDs Market Dynamics
  1. 2.1 NSAIDs Industry Trends
  2. 2.2 NSAIDs Industry Drivers
  3. 2.3 NSAIDs Industry Opportunities and Challenges
  4. 2.4 NSAIDs Industry Restraints
3 NSAIDs Market by Manufacturers
  1. 3.1 Global NSAIDs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global NSAIDs Sales by Manufacturers (2021-2026)
  3. 3.3 Global NSAIDs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global NSAIDs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global NSAIDs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global NSAIDs Manufacturers, Product Type & Application
  7. 3.7 Global NSAIDs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global NSAIDs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 NSAIDs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 NSAIDs Tier 1, Tier 2, and Tier 3
4 NSAIDs Market by Type
  1. 4.1 NSAIDs Type Introduction
  2. 4.1.1 Naproxen
  3. 4.1.2 Nabumetone
  4. 4.1.3 Ibuprofen
  5. 4.1.4 Aspirin
  6. 4.1.5 Others
  7. 4.2 Global NSAIDs Sales by Type
  8. 4.2.1 Global NSAIDs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global NSAIDs Sales by Type (2021-2032)
  10. 4.2.3 Global NSAIDs Sales Market Share by Type (2021-2032)
  11. 4.3 Global NSAIDs Revenue by Type
  12. 4.3.1 Global NSAIDs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global NSAIDs Revenue by Type (2021-2032)
  14. 4.3.3 Global NSAIDs Revenue Market Share by Type (2021-2032)
5 NSAIDs Market by Application
  1. 5.1 NSAIDs Application Introduction
  2. 5.1.1 Back Pain Treatment
  3. 5.1.2 Osteoarthritis Treatment
  4. 5.1.3 Other Disease Treatment
  5. 5.2 Global NSAIDs Sales by Application
  6. 5.2.1 Global NSAIDs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global NSAIDs Sales by Application (2021-2032)
  8. 5.2.3 Global NSAIDs Sales Market Share by Application (2021-2032)
  9. 5.3 Global NSAIDs Revenue by Application
  10. 5.3.1 Global NSAIDs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global NSAIDs Revenue by Application (2021-2032)
  12. 5.3.3 Global NSAIDs Revenue Market Share by Application (2021-2032)
6 Global NSAIDs Sales by Region
  1. 6.1 Global NSAIDs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global NSAIDs Sales by Region (2021-2032)
  3. 6.2.1 Global NSAIDs Sales by Region (2021-2026)
  4. 6.2.2 Global NSAIDs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America NSAIDs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe NSAIDs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific NSAIDs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa NSAIDs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa NSAIDs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global NSAIDs Revenue by Region
  1. 7.1 Global NSAIDs Revenue by Region
  2. 7.1.1 Global NSAIDs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global NSAIDs Revenue by Region (2021-2026)
  4. 7.1.3 Global NSAIDs Revenue by Region (2027-2032)
  5. 7.1.4 Global NSAIDs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America NSAIDs Revenue (2021-2032)
  8. 7.2.2 North America NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe NSAIDs Revenue (2021-2032)
  11. 7.3.2 Europe NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific NSAIDs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa NSAIDs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa NSAIDs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Cigna
  2. 8.1.1 Cigna Company Information
  3. 8.1.2 Cigna Business Overview
  4. 8.1.3 Cigna NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Cigna NSAIDs Product Portfolio
  6. 8.1.5 Cigna Recent Developments
  7. 8.2 Geri-Care Pharmaceuticals
  8. 8.2.1 Geri-Care Pharmaceuticals Company Information
  9. 8.2.2 Geri-Care Pharmaceuticals Business Overview
  10. 8.2.3 Geri-Care Pharmaceuticals NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Geri-Care Pharmaceuticals NSAIDs Product Portfolio
  12. 8.2.5 Geri-Care Pharmaceuticals Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline NSAIDs Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 Kopran
  20. 8.4.1 Kopran Company Information
  21. 8.4.2 Kopran Business Overview
  22. 8.4.3 Kopran NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kopran NSAIDs Product Portfolio
  24. 8.4.5 Kopran Recent Developments
  25. 8.5 Novacap
  26. 8.5.1 Novacap Company Information
  27. 8.5.2 Novacap Business Overview
  28. 8.5.3 Novacap NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novacap NSAIDs Product Portfolio
  30. 8.5.5 Novacap Recent Developments
  31. 8.6 Perrigo Company
  32. 8.6.1 Perrigo Company Company Information
  33. 8.6.2 Perrigo Company Business Overview
  34. 8.6.3 Perrigo Company NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Perrigo Company NSAIDs Product Portfolio
  36. 8.6.5 Perrigo Company Recent Developments
  37. 8.7 Reddy Pharmaceuticals
  38. 8.7.1 Reddy Pharmaceuticals Company Information
  39. 8.7.2 Reddy Pharmaceuticals Business Overview
  40. 8.7.3 Reddy Pharmaceuticals NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Reddy Pharmaceuticals NSAIDs Product Portfolio
  42. 8.7.5 Reddy Pharmaceuticals Recent Developments
  43. 8.8 Sun Pharmaceutical Industries
  44. 8.8.1 Sun Pharmaceutical Industries Company Information
  45. 8.8.2 Sun Pharmaceutical Industries Business Overview
  46. 8.8.3 Sun Pharmaceutical Industries NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharmaceutical Industries NSAIDs Product Portfolio
  48. 8.8.5 Sun Pharmaceutical Industries Recent Developments
  49. 8.9 Verywell
  50. 8.9.1 Verywell Company Information
  51. 8.9.2 Verywell Business Overview
  52. 8.9.3 Verywell NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Verywell NSAIDs Product Portfolio
  54. 8.9.5 Verywell Recent Developments
  55. 8.10 Bayer
  56. 8.10.1 Bayer Company Information
  57. 8.10.2 Bayer Business Overview
  58. 8.10.3 Bayer NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bayer NSAIDs Product Portfolio
  60. 8.10.5 Bayer Recent Developments
  61. 8.11 Pfizer
  62. 8.11.1 Pfizer Company Information
  63. 8.11.2 Pfizer Business Overview
  64. 8.11.3 Pfizer NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pfizer NSAIDs Product Portfolio
  66. 8.11.5 Pfizer Recent Developments
  67. 8.12 Merck Sharp & Dohme
  68. 8.12.1 Merck Sharp & Dohme Company Information
  69. 8.12.2 Merck Sharp & Dohme Business Overview
  70. 8.12.3 Merck Sharp & Dohme NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck Sharp & Dohme NSAIDs Product Portfolio
  72. 8.12.5 Merck Sharp & Dohme Recent Developments
  73. 8.13 Johnson & Johnson
  74. 8.13.1 Johnson & Johnson Company Information
  75. 8.13.2 Johnson & Johnson Business Overview
  76. 8.13.3 Johnson & Johnson NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Johnson & Johnson NSAIDs Product Portfolio
  78. 8.13.5 Johnson & Johnson Recent Developments
  79. 8.14 Abbott
  80. 8.14.1 Abbott Company Information
  81. 8.14.2 Abbott Business Overview
  82. 8.14.3 Abbott NSAIDs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Abbott NSAIDs Product Portfolio
  84. 8.14.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 NSAIDs Value Chain Analysis
  2. 9.1.1 NSAIDs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 NSAIDs Production Mode & Process
  6. 9.2 NSAIDs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 NSAIDs Distributors
  9. 9.2.3 NSAIDs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst